ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1856

Subclinical Coronary Artery Disease in Patients with Idiopathic Inflammatory Myopathies: A Cross-Sectional Study Evaluation by Computer Tomography Coronary Angiogram

Tsz Ho Luk1, Weng Nga Lao1, Steve Pang1, Ho So2, Tak Lung Wong3 and Yan Ki Tang4, 1Kwong Wah Hospital, Hong Kong, Hong Kong, 2Chinese University of Hong Kong, Hong Kong, Hong Kong, 3KWH, Kowloon, Hong Kong, 4Kwong Wah Hospital, Hong Kong, China

Meeting: ACR Convergence 2022

Keywords: Cardiovascular, Computed tomography (CT), Myositis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Muscle Biology, Myositis and Myopathies Poster II

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Idiopathic inflammatory myopathy (IIM) poses elevated risk of cardiovascular event and mortality, similar to other autoimmune rheumatic diseases. With the use of computer tomography coronary angiogram (CTCA), this study aimed to examine the prevalence and risk factors of subclinical coronary artery disease (CAD) in patients with IIM.

Methods: This was a single center, cross-sectional study. CTCA was performed to access the prevalence of CAD in IIM patients without cardiac symptoms, compared with age and sex matched control. Comparisons of traditional cardiovascular risk factors, myositis disease characteristics, medication usage, ejection fraction by echocardiogram between IIM patients with and without obstructive CAD were performed to identify the potential risk factors of obstructive CAD in IIM.

Results: Thirty IIM patients and thirty age, sex matched controls were recruited. The clinical characteristics of IIM patients were shown in Table 1. Prevalences of obstructive CAD and CAD in IIM (13.3%, 66.7% respectively) were significantly higher than control group (0%, 30% respectively, with p< 0.001). There was higher prevalence of mixed plaque in IIM than control (16.7% versus 0%, p=0.02). Diabetes mellitus [adjusted OR 34.5 (95% CI 2.35, 505.75), p=0.01] was found to be independent predictor of obstructive CAD. Age [adjusted coefficient 4.19 (95% CI 1.68, 6.71), p=0.02], maximum level of LDH (IU/L)/100 [adjusted coefficient 14.68 (95% CI 7.22, 22.12) , p< 0.001] and fasting glucose (mmol/L) [adjusted coefficient 48.55 (95% CI 7.61, 89.49), p=0.022] were found to be independently associated with coronary calcification score in IIM with CAD.

Conclusion: This study demonstrated an elevated risk of CAD compared with controls, with diabetes mellitus as a risk factor of developing obstructive CAD. Screening and aggressive treatment of cardiovascular risk factors in high risk IIM patients should be considered.

Supporting image 1

CTCA outcome in IIM and control

Supporting image 2

Result of linear regression of CAC against disease variable

Supporting image 3

Characteristics of IIM patients


Disclosures: T. Luk, None; W. Lao, None; S. Pang, None; H. So, None; T. Wong, None; Y. Tang, None.

To cite this abstract in AMA style:

Luk T, Lao W, Pang S, So H, Wong T, Tang Y. Subclinical Coronary Artery Disease in Patients with Idiopathic Inflammatory Myopathies: A Cross-Sectional Study Evaluation by Computer Tomography Coronary Angiogram [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/subclinical-coronary-artery-disease-in-patients-with-idiopathic-inflammatory-myopathies-a-cross-sectional-study-evaluation-by-computer-tomography-coronary-angiogram/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/subclinical-coronary-artery-disease-in-patients-with-idiopathic-inflammatory-myopathies-a-cross-sectional-study-evaluation-by-computer-tomography-coronary-angiogram/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology